230 related articles for article (PubMed ID: 31950968)
21. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
Yu Y; Chen CK; Law WC; Weinheimer E; Sengupta S; Prasad PN; Cheng C
Biomacromolecules; 2014 Feb; 15(2):524-32. PubMed ID: 24446700
[TBL] [Abstract][Full Text] [Related]
22. pH-controlled gas-generating mineralized nanoparticles: a theranostic agent for ultrasound imaging and therapy of cancers.
Min KH; Min HS; Lee HJ; Park DJ; Yhee JY; Kim K; Kwon IC; Jeong SY; Silvestre OF; Chen X; Hwang YS; Kim EC; Lee SC
ACS Nano; 2015 Jan; 9(1):134-45. PubMed ID: 25559896
[TBL] [Abstract][Full Text] [Related]
23. Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery.
Park JH; Cho HJ; Termsarasab U; Lee JY; Ko SH; Shim JS; Yoon IS; Kim DD
Colloids Surf B Biointerfaces; 2014 Sep; 121():380-7. PubMed ID: 24993066
[TBL] [Abstract][Full Text] [Related]
24. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
25. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy.
Cheng X; Zeng X; Zheng Y; Fang Q; Wang X; Wang J; Tang R
J Colloid Interface Sci; 2020 Apr; 565():254-269. PubMed ID: 31978788
[TBL] [Abstract][Full Text] [Related]
26. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH
J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585
[TBL] [Abstract][Full Text] [Related]
27. Surface modification of pH-sensitive honokiol nanoparticles based on dopamine coating for targeted therapy of breast cancer.
Yu R; Zou Y; Liu B; Guo Y; Wang X; Han M
Colloids Surf B Biointerfaces; 2019 May; 177():1-10. PubMed ID: 30690424
[TBL] [Abstract][Full Text] [Related]
28. In situ mineralization of anticancer drug into calcium carbonate monodisperse nanospheres and their pH-responsive release property.
Yang T; Wan Z; Liu Z; Li H; Wang H; Lu N; Chen Z; Mei X; Ren X
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():384-92. PubMed ID: 27040233
[TBL] [Abstract][Full Text] [Related]
29. Smart responsive-calcium carbonate nanoparticles for dual-model cancer imaging and treatment.
Huang H; Zhang W; Liu Z; Guo H; Zhang P
Ultrasonics; 2020 Dec; 108():106198. PubMed ID: 32590261
[TBL] [Abstract][Full Text] [Related]
30. pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer.
Yuan JD; ZhuGe DL; Tong MQ; Lin MT; Xu XF; Tang X; Zhao YZ; Xu HL
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):302-313. PubMed ID: 29301415
[TBL] [Abstract][Full Text] [Related]
31. Na
Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
[TBL] [Abstract][Full Text] [Related]
32. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
[TBL] [Abstract][Full Text] [Related]
33. Co-delivery of carboplatin and doxorubicin using ZIF-8 coated chitosan-poly(N-isopropyl acrylamide) nanoparticles through a dual pH/thermo responsive strategy to breast cancer cells.
Dashti N; Akbari V; Varshosaz J; Soleimanbeigi M; Rostami M
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131971. PubMed ID: 38705336
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
35. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
36. Preparation Optimization of Bovine Serum Albumin Nanoparticles and Its Application for siRNA Delivery.
Wang Y; Chen S; Yang X; Zhang S; Cui C
Drug Des Devel Ther; 2021; 15():1531-1547. PubMed ID: 33883877
[TBL] [Abstract][Full Text] [Related]
37. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery.
Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X
Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507
[TBL] [Abstract][Full Text] [Related]
38. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells.
Haque ST; Islam RA; Gan SH; Chowdhury EH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817
[No Abstract] [Full Text] [Related]
39. pH-sensitive amphiphilic chitosan-quercetin conjugate for intracellular delivery of doxorubicin enhancement.
Mu Y; Wu G; Su C; Dong Y; Zhang K; Li J; Sun X; Li Y; Chen X; Feng C
Carbohydr Polym; 2019 Nov; 223():115072. PubMed ID: 31427010
[TBL] [Abstract][Full Text] [Related]
40. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
